<DOC>
	<DOCNO>NCT01855243</DOCNO>
	<brief_summary>Purpose : To compare efficacy safety traditional slide scale insulin ( SSI ) versus modify 70/30 insulin versus modify basal plus supplemental scale /bolus insulin regimens glycemic control hospitalize diabetic patient diabetes . Methods : In prospective trial , patient diabetes randomized receive either traditional hospital SSI , twice daily 70/30 insulin plus supplemental lunchtime insulin BG ≥ 150 mg/dL every night glargine plus three time prandial glulisine BG ≥ 150 mg/dL . 70/30 insulin glargine start respectively 0.4 0.2 U/kg/day BG ≤ 200 mg/dL 0.5 0.3 U/kg/day BG 200 mg/dL .</brief_summary>
	<brief_title>Comparison Efficacy Safety Three Inpatient Insulin Therapy Type2 DM</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>know history type 2 DM longer 3 month age 1864 year old , treatment diet alone , combination oral antidiabetic agent and/or insulin admission . subject hyperglycemia without know history DM presence diabetic ketoacidosis ( DKA ) patient admit intensive care unit ( ICU ) subject expect undergo surgery hospitalization course patient clinically relevant hepatic disease impair renal function ( serum creatinine ≥ 3.0 mg/dL ) systemic infection pregnancy patient medication know interfere blood glucose level ( either increase decreasing</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Type 2 D M</keyword>
	<keyword>slide scale insulin</keyword>
	<keyword>70/30 insulin</keyword>
	<keyword>basals insulin</keyword>
	<keyword>supplemental insulin</keyword>
</DOC>